$1.25 million awarded to progress University of Queensland-developed prostate cancer drug

Development of a new drug based on research at The University of Queensland, targeting advanced and therapy-resistant prostate cancer, has been awarded $1.25 million from the US-based Critical Path Institute’s Translational Therapeutics Accelerator. According to a statement from UQ on Tuesday, the drug named QED-203 has its origins in research by Professor Greg Monteith from…

Industry 4.0 guru to ask: will Australia be left behind in the current Industrial Revolution?

Professor Henrik von Scheel (pictured), an internationally-recognised strategist and futurist known as the man who coined the term Industry 4.0, will feature at the upcoming Industrial Transformation Australia event in Sydney this July. According to a statement from event organisers Hannover Fairs Australia on Monday, von Scheel will reveal what will influence the success of…

ClearVue expands into New Zealand with Viridian Glass deal

Building-integrated solar PV company ClearVue Technologies has announced a manufacturing and distribution agreement with Viridian Glass, which will see the Perth-based company enter the New Zealand market. In an ASX statement on Monday, ClearVue said the five-year deal involves NZ’s leading glass processor making and distributing ClearVue’s solar-integrated glazing solutions within that country.  Global CEO…

Manufacturing news briefs — stories you might have missed

Titomic signs collaboration agreement with DNV  Last week cold spray additive manufacturing company Titomic announced a strategic collaboration agreement with DNV, an assurance and risk management provider. According to a statement from Titomic, it will advance Titomic’s efforts to obtain certifications for its coating and repair technologies across the oil and gas and maritime sectors,…